Save the date!
Biotech Showcase 2023,
January 9–11, 2023

Welcome to Biotech Showcase Digital 2021

Please enjoy the live recordings of these free panel sessions.

Part 1–The world according to COVID-19: From crisis to long-term impact

Leah Rosenbaum – Assistant Editor, Healthcare & Science, Forbes
Jeremy Levin – CEO, Ovid Therapeutics; Board of Directors Chair, Biotechnology Innovation Organization (BIO)
Michelle McMurry-Heath – President and CEO, Biotechnology Innovation Organization (BIO)

The path forward

Sara Jane Demy - CEO and Founder, Demy-Colton
Rick Bright - Former Director, Biomedical Advanced Research and Development Authority (BARDA), Transition Team, COVID-19 Advisory Board

By registering you can join the full conference, including 25+ panels and over 350 public and private company presentations. To date over 2,200 delegates are in attendance, including over 750 global investors.

COVID-19 therapeutics: A review of the options

Stephen G. Brozak, Managing Partner and President, WBB Securities LLC
Prabhavathi Fernandes,Chair, National Biodefense Science Board
Michael Kurilla, Director of Division of Clinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health

In the Balance the humanitarian perspective

Jeremy Abbate, Publisher, Scientific American
Ruxandra Draghia-Akli, Global Head, Johnson & Johnson Global Public Health R&D
Amy Finan, CEO, Sabin Vaccine Institute
Richard Hatchett, CEO, CEPI